These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22176920)

  • 1. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis.
    Bai P; Sun Y; Jin J; Hou J; Li R; Zhang Q; Wang Y
    Respir Res; 2011 Dec; 12(1):157. PubMed ID: 22176920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis.
    Zhang PF; Pan L; Luo ZY; Zhao HJ; Cai SX
    COPD; 2013 Dec; 10(6):650-6. PubMed ID: 23845033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
    Xu S; Wang Y; Lu J; Xu J
    Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19.
    Kazemi-Sufi S; Alipour S; Rabieepour M; Roshan-Milani S; Naderi R
    BMC Infect Dis; 2024 Sep; 24(1):1047. PubMed ID: 39333916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
    Ali R; Hammad A; El-Nahrery E; Hamdy N; Elhawary AK; Eid R
    Lupus; 2019 Sep; 28(10):1233-1242. PubMed ID: 31403902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major.
    Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Malaktari S; Athanasiou V; Tolis G
    J Bone Miner Metab; 2007; 25(1):60-7. PubMed ID: 17187195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
    Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
    Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
    Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
    Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
    Zupan J; Komadina R; Marc J
    J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease.
    Ugay L; Kochetkova E; Nevzorova V; Maistrovskaia Y
    Chin Med J (Engl); 2016 Jul; 129(14):1696-703. PubMed ID: 27411457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD.
    Pobeha P; Petrasova D; Tkacova R; Joppa P
    Respir Med; 2014 Apr; 108(4):621-7. PubMed ID: 24424018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: A potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors.
    Taylan A; Birlik M; Kenar G; Toprak B; Gundogdu B; Gurler O; Karakas B; Akıncı B; Sisman AR
    Mod Rheumatol; 2019 Jul; 29(4):619-624. PubMed ID: 30001654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease].
    Kochetkova EA; Nevzorova VA; Maĭstrovskaia IuV; Massard G
    Ter Arkh; 2010; 82(8):10-4. PubMed ID: 20873238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study.
    Amer OE; Wani K; Ansari MGA; Alnaami AM; Aljohani N; Abdi S; Hussain SD; Al-Daghri NM; Alokail MS
    Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 35893092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
    Shang M; Lin L; Cui H
    Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Tumor Necrosis Factor Alpha and TNF Superfamily Members in Bone Damage in Patients with End-Stage Chronic Obstructive Lung Disease Prior to Lung Transplantation.
    Kochetkova EA; Nevzorova VA; Ugai LG; Maistrovskaia YV; Massard G
    Calcif Tissue Int; 2016 Dec; 99(6):578-587. PubMed ID: 27501819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Marek B; Świętochowska E; Kajdaniuk D; Strzelczyk J; Cieślicka A; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2015; 66(4):313-21. PubMed ID: 26323468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.